The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Intuitive Surgical Inc

Nasdaq: ISRG
Last

(U.S.) $514.24

Today's change-1.33 -0.26%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Intuitive Surgical Inc

Nasdaq: ISRG
Last

(U.S.) $514.24

Today's change-1.33 -0.26%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Intuitive Surgical Inc down (U.S.)$1.33

Intuitive Surgical Inc closed lower Friday, dropping (U.S.)$1.33 or 0.26% to (U.S.)$514.24. Over the last five days, shares have gained 1.46%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 10.85% during the last year.

Key company metrics

  • Open(U.S.) $512.39
  • Previous close(U.S.) $515.57
  • High(U.S.) $516.49
  • Low(U.S.) $510.79
  • Bid / Ask-- / --
  • YTD % change-2.78%
  • Volume135,743
  • Average volume (10-day)284,618
  • Average volume (1-month)244,334
  • Average volume (3-month)283,381
  • 52-week range(U.S.) $449.34 to (U.S.) $564.86
  • Beta0.60
  • Trailing P/E38.32×
  • P/E 1 year forward29.64×
  • Forward PEG2.31×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $13.42
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+22.09%

Based on its net profit margin of 22.09%, Intuitive Surgical Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue586532605550
Total other revenue--------
Total revenue586532605550
Gross profit387337393361
Total cost of revenue200195211190
Total operating expense412402419391
Selling / general / administrative163162160154
Research & development49444748
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income174130186159
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax178135185161
Income after tax13597147124
Income tax, total44383837
Net income13597147124
Total adjustments to net income--------
Net income before extra. items13597147124
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items13597147124
Inc. avail. to common incl. extra. items13597147124
Diluted net income13597147124
Dilution adjustment0--00
Diluted weighted average shares38383737
Diluted EPS excluding extraordinary itemsvalue per share3.562.573.943.35
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share3.562.573.943.35